Company news
Diaceutics Plc (LSE:DXRX) news
Diaceutics Plc news releases on 6ix. Latest, Aug 27, 2024: Diaceutics Launches Enhanced Rare-Disease Offering
Press releases — page 2
Diaceutics Launches Enhanced Rare-Disease Offering
August 27, 2024
Enterprise Partnership and Launch of PMx
August 19, 2024
Presenting at Canaccord Genuity Growth Conference
August 5, 2024
PDMR Shareholding/SIP and TVR
July 29, 2024
Revenue growth of 24% in H1 with 55% now recurring
July 23, 2024
Senior Management Appointments
July 11, 2024
Result of AGM
June 24, 2024
"Precision Medicine in Oncology " Virtual Event
June 13, 2024
Diaceutics - Capital Markets Event
June 6, 2024
Data to be Presented at 2024 ASCO Annual Meeting
May 28, 2024
Director / PDMR Shareholding
May 23, 2024
Revenue growth of 22% & order book growth of 57%
May 21, 2024
Two New Enterprise-Wide Engagements
May 16, 2024
Appointment of Amie Mc Neice as VP of Marketing
April 9, 2024
Director/PDMR/PCA Shareholding & TR1
April 2, 2024
Significant upgrade to Diaceutics' DXRX platform
March 21, 2024
Diaceutics forms landmark industry Forum
March 19, 2024
Director/PDMR Shareholding
March 7, 2024
PDMR Shareholding / SIP and TVR
March 1, 2024
Expanded lab network and data capabilities
February 27, 2024
Diaceutics PLC - Strategic alliance with KPMG
February 14, 2024
Appointment of VP, Scientific & Medical Services
February 5, 2024
Diaceutics PLC – Trading Update
January 30, 2024
Exercise of Warrant & Total Voting Rights
January 25, 2024
Diaceutics PLC – Financial Calendar Update
January 19, 2024
Diaceutics to attend Stifel Conference in NYC
November 30, 2023
Notification of Major Holdings
November 21, 2023
Block Listing Application to AIM
October 2, 2023
Diaceutics PLC – Half Year Results
September 26, 2023
Diaceutics PLC – Directorate Changes
September 21, 2023
Attending 10th Annual HealthTech Investment Forum
September 7, 2023
Notice of Interim Results and Presentations
September 5, 2023
Diaceutics launches daily alerts for DXRX platform
August 29, 2023
Canaccord Genuity 43rd Annual Growth Conference
August 4, 2023
Trading Update and Notice of Results
July 25, 2023
Purchase and Sale of Shares and PDMR Shareholdings
June 6, 2023
USD 10.1 million multi-year enterprise engagement
June 5, 2023
Results of Annual General Meeting
May 18, 2023
PDMR Shareholdings
May 11, 2023
PDMR shareholdings
May 4, 2023
PDMR Shareholding
April 26, 2023
Final Results
April 17, 2023
PDMR Shareholding / Share Incentive Plan
April 3, 2023
Notice of Results and Presentations
March 20, 2023
Further update regarding Silicon Valley Bank
March 13, 2023
USD 7m enterprise engagements for data services
January 26, 2023
Change of Auditor
November 29, 2022
Sub-optimal testing impacts on cancer patients
November 1, 2022
Half-year Report
September 27, 2022
Multi-year contract with top five global pharma
June 13, 2022